These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35342138)

  • 101. Extraordinary claims without extraordinary evidence: controversy on anti-androgen therapy for COVID-19.
    Trüeb RM; Régnier A; Caballero-Uribe N; Reis Gavazzoni Dias MF; Dutra Rezende H
    J Eur Acad Dermatol Venereol; 2021 Aug; 35(8):e494-e495. PubMed ID: 33783855
    [No Abstract]   [Full Text] [Related]  

  • 102. COVID-19 and endocrine disorders: a potential new trigger.
    Capó X; Annunziata G; Jiménez-Garcia M; Muscogiuri G; Barrea L
    Minerva Med; 2023 Dec; 114(6):767-769. PubMed ID: 37800449
    [No Abstract]   [Full Text] [Related]  

  • 103. Corrigendum: Hematological profile, inflammatory markers and serum liver enzymes in COVID 19 positive children vs. COVID 19 negative ones-a comparative study.
    Pavelescu ML; Dinulescu A; Păsărică AS; Dijmărescu I; Păcurar D
    Front Pediatr; 2024; 12():1401564. PubMed ID: 38633327
    [TBL] [Abstract][Full Text] [Related]  

  • 104. [Hematologic diseases in the Japanese].
    Takatsuki K
    Rinsho Ketsueki; 1997 Mar; 38(3):162-5. PubMed ID: 9095649
    [No Abstract]   [Full Text] [Related]  

  • 105. [The main progresses and hot spots of hematological diseases in the past decade].
    Tang FF; Huang XJ
    Zhonghua Nei Ke Za Zhi; 2024 Apr; 63(4):321-327. PubMed ID: 38561275
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Severe COVID-19 outcomes and hematological cancers: the clot thickens-are platelets the culprit?
    Lichtenberger LM; Vijayan KV
    Transl Cancer Res; 2023 Sep; 12(9):2425-2428. PubMed ID: 37859735
    [No Abstract]   [Full Text] [Related]  

  • 107. COVID-19: A hematological perspective.
    Nayak L; Zheng Z
    Best Pract Res Clin Haematol; 2022 Sep; 35(3):101412. PubMed ID: 36494151
    [No Abstract]   [Full Text] [Related]  

  • 108. Can anti-TNFα Antibodies Affect SARS-CoV-2 Disease Outcomes?
    Khazdair MR
    Adv Pharm Bull; 2022 May; 12(3):423. PubMed ID: 35935052
    [No Abstract]   [Full Text] [Related]  

  • 109. Clinical Efficacy of Imdevimab/Casirivimab for Persistent Omicron SARS-CoV-2 Infection in Patients with Hematological Malignancies.
    Hagihara M; Hayashi H; Nakashima S; Imai Y; Nakano H; Uchida T; Inoue M; Sakai-Tagawa Y; Ito M; Yamayoshi S; Iwatsuki-Horimoto K; Suzuki Y; Kawaoka Y
    Intern Med; 2024 Aug; 63(16):2283-2287. PubMed ID: 38171874
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Imaging of Hematological Patients in the Era of COVID-19.
    Eshet Y; Avigdor A; Kedmi M; Tau N
    Acta Haematol; 2022; 145(3):267-274. PubMed ID: 35100592
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Anti-SARS CoV-2 IgG in COVID-19 Patients with Hematological Diseases: A Single-center, Retrospective Study in Japan.
    Fujii T; Hagihara M; Mitamura K; Nakashima S; Ohara S; Uchida T; Inoue M; Okuda M; Yasuhara A; Murakami J; Duong C; Iwatsuki-Horimoto K; Yamayoshi S; Kawaoka Y
    Intern Med; 2022 Jun; 61(11):1681-1686. PubMed ID: 35342138
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan.
    Yazaki S; Yoshida T; Kojima Y; Yagishita S; Nakahama H; Okinaka K; Matsushita H; Shiotsuka M; Kobayashi O; Iwata S; Narita Y; Ohba A; Takahashi M; Iwasa S; Kobayashi K; Ohe Y; Yoshida T; Hamada A; Doi T; Yamamoto N
    JAMA Oncol; 2021 Aug; 7(8):1141-1148. PubMed ID: 34047762
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Validation of a new automated chemiluminescent anti-SARS-CoV-2 IgM and IgG antibody assay system detecting both N and S proteins in Japan.
    Yokoyama R; Kurano M; Morita Y; Shimura T; Nakano Y; Qian C; Xia F; He F; Kishi Y; Okada J; Yoshikawa N; Nagura Y; Okazaki H; Moriya K; Seto Y; Kodama T; Yatomi Y
    PLoS One; 2021; 16(3):e0247711. PubMed ID: 33661990
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery.
    Yang YJ; Murphy EA; Singh S; Sukhu AC; Wolfe I; Adurty S; Eng D; Yee J; Mohammed I; Zhao Z; Riley LE; Prabhu M
    Obstet Gynecol; 2022 Mar; 139(3):373-380. PubMed ID: 34963127
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Antibody responses to SARS-CoV-2 nucleocapsid and spike proteins in hospitalized patients with COVID-19: A multicenter, retrospective, cross-sectional study in Japan.
    Hibino M; Watanabe S; Tobe S; Maeda K; Horiuchi S; Nishiguchi S; Iwase A; Uryu K; Kobayashi S; Kondo T
    Respir Investig; 2022 Mar; 60(2):256-263. PubMed ID: 34924308
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Patterns of seroconversion for SARS-CoV2-IgG in patients with malignant disease and association with anticancer therapy.
    Thakkar A; Pradhan K; Jindal S; Cui Z; Rockwell B; Shah AP; Packer S; Sica RA; Sparano J; Goldstein DY; Verma A; Goel S; Halmos B
    Nat Cancer; 2021 Apr; 2(4):392-399. PubMed ID: 34661163
    [TBL] [Abstract][Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.